Educational Objective:
To interpret the results of clinical trials of potentially neuroprotective drugs for Parkinson disease.

CME HOME | JAMA & ARCHIVES HOME | MY CME | SUBSCRIBE | E-MAIL ALERTS | HELP CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP   © 2008 American Medical Association Journals Continuing Medical Education Program. All Rights Reserved.